Turska odobrila hitnu upotrebu ruskih vakcina Sputnik V
Turska je odobrila hitnu upotrebu ruskih vakcina protiv koronavirusa Sputnik V, objavio je u petak Fahrettin Koca, ministar zdravlja Republike Turske.
– Hitna upotreba vakcina Sputnik V odobrena je nakon procjena turske Agencije za lijekove i medicinske uređaje – naveo je Koca na Twitteru.
On je dodao da će ruske vakcine postati treće koje se koriste u Turskoj protiv COVID-19, nakon kineskog Sinovca i vakcina BioNTech.
Koca je prethodno rekao novinarima da je Turska potpisala sporazum o prijemu 50 miliona doza ruskih vakcina tokom šest mjeseci počevši od maja.
Turska je 14. januara pokrenula kampanju masovne vakcinacije, počevši od zdravstvenih radnika, a do sada je dato više od 22,8 miliona doza vakcina. Prvu dozu primilo je oko 13,7 miliona ljudi, a oko 9,1 milion osoba je potpuno vakcinisano.
I'm so happy to read this. This is the type of manual that needs to be given and not the random misinformation that's at the other blogs. Appreciate your sharing this best doc.
You made some first rate points there. I seemed on the web for the issue and located most individuals will associate with together with your website.
After all, what a great site and informative posts, I will upload inbound link – bookmark this web site? Regards, Reader.
I believe other website proprietors should take this internet site as an example , very clean and excellent user friendly layout.
You can certainly see your enthusiasm in the paintings you write. The sector hopes for more passionate writers such as you who aren't afraid to say how they believe. All the time follow your heart.
you're truly a just right webmaster. The website loading pace is incredible. It seems that you are doing any distinctive trick. Furthermore, The contents are masterwork. you have performed a wonderful task in this topic!
I like this blog very much, Its a really nice office to read and receive information.
There is obviously a lot to identify about this. I believe you made certain good points in features also.